Document is current
Any future updates will be listed below
-
Authors
Han, Xuexiang https://orcid.org/0000-0003-0011-5222
Gong, Ningqiang https://orcid.org/0000-0002-9444-8505
Xue, Lulu https://orcid.org/0000-0001-5719-1336
Billingsley, Margaret M.
El-Mayta, Rakan
Shepherd, Sarah J.
Alameh, Mohamad-Gabriel https://orcid.org/0000-0002-5672-6930
Weissman, Drew
Mitchell, Michael J. https://orcid.org/0000-0002-3628-2244
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP2 TR002776, DP2 TR002776)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 12 August 2022
Accepted: 14 December 2022
First Online: 17 January 2023
Competing interests
: X.H. and M.J.M. are inventors on a patent filed by the Trustees of the University of Pennsylvania (U.S. Provisional Patent Application No. 63/286,760, filed December 7, 2021) describing the ligand-tethered lipid nanoparticle technology in this manuscript. All other authors declare they have no competing interests.
